# A Study to Test the Safety of Three Experimental HIV Vaccines

> **NCT00000946** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 40 (—)

## Conditions studied

- HIV Infections
- HIV Seronegativity

## Interventions

- **BIOLOGICAL:** HIV p24/MF59 Vaccine
- **BIOLOGICAL:** ALVAC-HIV MN120TMG (vCP205)
- **BIOLOGICAL:** ALVAC-RG Rabies Glycoprotein (vCP65)
- **BIOLOGICAL:** rgp120/HIV-1 SF-2

## Key facts

- **NCT ID:** NCT00000946
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 2001-03
- **Target enrollment:** 40 (—)
- **Last updated:** 2021-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000946, "A Study to Test the Safety of Three Experimental HIV Vaccines". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00000946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*